Literature DB >> 33336278

Scaffold-Based Delivery of CRISPR/Cas9 Ribonucleoproteins for Genome Editing.

Wai Hon Chooi1, Jiah Shin Chin1,2, Sing Yian Chew3,4.   

Abstract

The simple and versatile CRISPR/Cas9 system is a promising strategy for genome editing in mammalian cells. Generally, the genome editing components, namely Cas9 protein and single-guide RNA (sgRNA), are delivered in the format of plasmids, mRNA, or ribonucleoprotein (RNP) complexes. In particular, non-viral approaches are desirable as they overcome the safety concerns posed by viral vectors. To control cell fate for tissue regeneration, scaffold-based delivery of genome editing components will offer a route for local delivery and provide possible synergistic effects with other factors such as topographical cues that are co-delivered by the same scaffold. In this chapter, we detail a simple method of surface modification to functionalize electrospun nanofibers with CRISPR/Cas9 RNP complexes. The mussel-inspired bio-adhesive coating will be used as it is a simple and effective method to immobilize biomolecules on the surface. Nanofibers will provide a biomimicking microenvironment and topographical cues to seeded cells. For evaluation, a model cell line with single copies of enhanced green fluorescent protein (U2OS.EGFP) will be used to validate the efficiency of gene disruption.

Entities:  

Keywords:  Cas9 protein; Electrospinning; Gene delivery; Ribonucleoprotein; Tissue engineering

Year:  2021        PMID: 33336278     DOI: 10.1007/978-1-0716-0943-9_13

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  15 in total

Review 1.  Growth factor release from tissue engineering scaffolds.

Authors:  M J Whitaker; R A Quirk; S M Howdle; K M Shakesheff
Journal:  J Pharm Pharmacol       Date:  2001-11       Impact factor: 3.765

Review 2.  Matrices and scaffolds for DNA delivery in tissue engineering.

Authors:  Laura De Laporte; Lonnie D Shea
Journal:  Adv Drug Deliv Rev       Date:  2007-04-14       Impact factor: 15.470

Review 3.  Non-viral delivery systems for CRISPR/Cas9-based genome editing: Challenges and opportunities.

Authors:  Ling Li; Shuo Hu; Xiaoyuan Chen
Journal:  Biomaterials       Date:  2018-04-18       Impact factor: 12.479

Review 4.  CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery.

Authors:  Hong-Xia Wang; Mingqiang Li; Ciaran M Lee; Syandan Chakraborty; Hae-Won Kim; Gang Bao; Kam W Leong
Journal:  Chem Rev       Date:  2017-06-22       Impact factor: 60.622

5.  A crisper look at genome editing: RNA-guided genome modification.

Authors:  Mara Damian; Matthew H Porteus
Journal:  Mol Ther       Date:  2013-04       Impact factor: 11.454

Review 6.  Development and applications of CRISPR-Cas9 for genome engineering.

Authors:  Patrick D Hsu; Eric S Lander; Feng Zhang
Journal:  Cell       Date:  2014-06-05       Impact factor: 41.582

7.  Nanofibrous scaffold-mediated REST knockdown to enhance neuronal differentiation of stem cells.

Authors:  Wei Ching Low; Pim-On Rujitanaroj; Dong-Keun Lee; Phillip B Messersmith; Lawrence W Stanton; Eyleen Goh; Sing Yian Chew
Journal:  Biomaterials       Date:  2013-02-14       Impact factor: 12.479

8.  Mussel-Inspired Modification of Nanofibers for REST siRNA Delivery: Understanding the Effects of Gene-Silencing and Substrate Topography on Human Mesenchymal Stem Cell Neuronal Commitment.

Authors:  Wei Ching Low; Pim-On Rujitanaroj; Dong-Keun Lee; Jinghao Kuang; Phillip B Messersmith; Jerry Kok Yen Chan; Sing Yian Chew
Journal:  Macromol Biosci       Date:  2015-06-19       Impact factor: 4.979

Review 9.  Therapeutic genome editing: prospects and challenges.

Authors:  David Benjamin Turitz Cox; Randall Jeffrey Platt; Feng Zhang
Journal:  Nat Med       Date:  2015-02       Impact factor: 53.440

10.  RNA-guided gene activation by CRISPR-Cas9-based transcription factors.

Authors:  Pablo Perez-Pinera; D Dewran Kocak; Christopher M Vockley; Andrew F Adler; Ami M Kabadi; Lauren R Polstein; Pratiksha I Thakore; Katherine A Glass; David G Ousterout; Kam W Leong; Farshid Guilak; Gregory E Crawford; Timothy E Reddy; Charles A Gersbach
Journal:  Nat Methods       Date:  2013-07-25       Impact factor: 28.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.